ROTHBLATT MARTINE A sold UTHR
September 26, 2025 · Form 4 insider transaction
ROTHBLATT MARTINE A sold 1,000 shares of United Therapeutics Corporation at $426.86 per share, a transaction worth $426.9K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 3 days after the transaction.
Direction
Disposed (sell-side)
Shares
1,000
Price
$426.86
Total value
$426.9K
InsiderROTHBLATT MARTINE A
RoleOfficer, Director
SecurityCommon Stock
Transaction codeS: Open-market sale
Transaction dateSeptember 26, 2025
Filing dateSeptember 29, 2025
Shares owned after3,130
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
This exercise and sale of stock options was pursuant to a pre-arranged 10b5-1 trading plan entered into by the reporting person on May 2, 2025. This plan will continue until the earlier of: (a) exhaustion of a tranche of 294,000 stock options that expire March 15, 2026; or (b) December 31, 2025.